Obermatt
See Similar Stocks →

Solid Biosciences

NSQ:SLDB · US83422E2046
BiotechnologySmall

360° View

no current rank
Price/Sales—
Price/Earnings30
Price/Book42
Dividend Yield—
Revenue Growth—
Profit Growth33
Capital Growth40
TSR 52w55
Leverage60
Liquidity49
Refinancing53
Combined—
Analyst Opinions52
Pro Holdings51
Opinion Changes50
Market Pulse45

Profile

CountryUSA
IndustryBiotechnology
SizeSmall
TypePublic Company
ExchangeNASDAQGS
Founded2013
Employees151
Websitesolidbio.com
ISINUS83422E2046
Last UpdateApr 2, 2026
Index & Theme
GeneticsNeurologyGenetic DisorderCentral Nervous SystemCardiovascularBiotechnologyMedical

Description

Solid Biosciences Inc. (Solid) is a life sciences company. The company is focused on advancing a portfolio of current and future gene therapy candidates, which the company refers to collectively as its Candidates, including SGT-003 for the treatment…

Similar Stocks

The companies this stock is ranked against.

Compare Solid Biosciences with its peers
Rocket Pharmaceuticals
NMQ:RCKT
31
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Beam Therapeutics
NSQ:BEAM
17
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Mink Therapeutics
NAQ:INKT
—
CountryUSA
IndustryBiotechnology
SizeX-Small
Full Stock Analysis →
Voyager Therapeutics
NSQ:VYGR
49
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Larimar Therapeutics
NMQ:LRMR
26
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →
Design Therapeutics
NSQ:DSGN
71
CountryUSA
IndustryBiotechnology
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →